Colossal Biosciences, known for its outlandish goal to resurrect the woolly mammoth by 2028, is claiming steady progress. Its evidence: genetically engineering mice to have mammoth-like fur.

Dallas-based Colossal says it is one step closer to bringing back the woolly mammoth. Colossal Biosciences announced Tuesday that it had created the Colossal woolly mouse, genetically engineered ...

Courtesy of Colossal Biosciences Colossal scientists see all of this work as just a first step in developing a more widely applicable de-extinction technology. In addition to the mammoth ...

May 05, 2025--(BUSINESS WIRE)--Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene editing platform to create potential one-time curative ...

A Texas company working to bring back the woolly mammoth has made an adorable breakthrough: the woolly mouse. Dallas-based Colossal Biosciences announced Tuesday that it has engineered mice with ...

Twenty years later and the bioengineering company Colossal Biosciences has set its sights on resurrecting the legendary woolly mammoth. But before that, they’ve delivered the most adorable ...

Mammoth Biosciences to Present Preclinical Data on In Vivo Gene Editing of Skeletal Muscle in Non-Human Primates with an Ultracompact CRISPR System at ASGCT 2025 Mammoth Biosciences, Inc., a ...

Behold, the woolly mouse. Scientists at the Dallas-based Colossal Biosciences have taken a small step towards their goal of bringing back the woolly mammoth: Colossal Woolly Mouse. "I'm excited ...

Colossal Biosciences caught our imagination – and ... cutting-edge genetics editing technology to bring back the woolly mammoth. This week, the company really turned heads with the release ...

Colossal Biosciences, a startup trying to bring the prehistoric mammoth back from extinction, said it has achieved a first step: the Woolly Mouse. Using DNA and genomics technologies, scientists ...

Colossal Biosciences not only wants to bring back the woolly mammoth—it wants to patent it, too. MIT Technology Review has learned the Texas startup is seeking a patent that would give it ...

Mammoth Biosciences Announces Nomination of MB-111 as First Development Candidate and Appoints Genetic Medicines Veteran Bob D. Brown to Board of Directors MB-111 is a potential first-in-class in ...